Abstract
BackgroundDrug expenses are increasing. Especially novel drugs affect these expenses significantly and existing budgeting forecasts have hitherto not contained accurate enough parameters for precise forecasting. We needed a model that...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have